Piper Sandler
RatingNeutral unchanged
Price target$9 → $6 −33.3% · −$3
Price at note$4.43 (Oct 23 close) +35.4% upside (+$1.57) to the $6 target
Third-party analyst actions
Analyst moves
Upgrades, downgrades, new coverage and price-target changes from Wall Street firms on the stocks we cover. What each firm published, laid out plainly. These are third-party actions, not our views.
Try one
117 moves · this month
ⓘ Rating colors
- Strong BuyConviction Buy, Top Pick, Top Pick Buy
- BuyLong Term Buy, Speculative Buy, Outright Buy
- OutperformOverweight, Accumulate, Moderate Buy, Positive
- HoldNeutral, Equal Weight, Market Perform, Sector Perform
- UnderperformUnderweight, Reduce, Moderate Sell, Negative
- Sell
- Strong Sell
- OtherRatings we can't place on the scale
Each firm's own wording is placed on one seven-step scale so ratings compare at a glance. ▲ / ▼ between two ratings marks an upgrade or a downgrade. The colours describe what the firm said; they are not our view.
Friday · Oct 23, 2026
ELVElevance Health$439.95TD Cowen
RatingBuy unchanged
Price target$465 → $495 +6.5% · +$30
Price at note$439.95 (Oct 23 close) +12.5% upside (+$55.05) to the $495 target
Evercore ISI Group
RatingOutperform unchanged
Price target$47 → $40 −14.9% · −$7
Price at note$27.52 (Oct 23 close) +45.3% upside (+$12.48) to the $40 target
Mizuho
RatingOutperform unchanged
Price target$43 → $37 −14.0% · −$6
Price at note$27.52 (Oct 23 close) +34.4% upside (+$9.48) to the $37 target
Thursday · Oct 22, 2026
ZSZscaler, Inc.$212.53Freedom Broker
RatingBuy unchanged
Price target$230 → $270 +17.4% · +$40
Price at note$212.53 (Oct 19 close, before the note) +27.0% upside (+$57.47) to the $270 target
ELVElevance Health$439.95UBS
RatingBuy unchanged
Price target$460 → $523 +13.7% · +$63
Price at note$445.28 (Oct 22 close) +17.5% upside (+$77.72) to the $523 target
ELVElevance Health$439.95Guggenheim
RatingBuy unchanged
Price target$460 → $485 +5.4% · +$25
Price at note$445.28 (Oct 22 close) +8.9% upside (+$39.72) to the $485 target
ELVElevance Health$439.95Morgan Stanley
RatingEqual-Weight unchanged
Price target$404 → $449 +11.1% · +$45
Price at note$445.28 (Oct 22 close) +0.8% upside (+$3.72) to the $449 target
ELVElevance Health$439.95RBC Capital
RatingSector Perform unchanged
Price target$424 → $455 +7.3% · +$31
Price at note$445.28 (Oct 22 close) +2.2% upside (+$9.72) to the $455 target
ELVElevance Health$439.95Barclays
RatingOverweight unchanged
Price target$469 → $472 +0.6% · +$3
Price at note$445.28 (Oct 22 close) +6.0% upside (+$26.72) to the $472 target
ELVElevance Health$439.95Baird
RatingNeutral unchanged
Price target$393 → $406 +3.3% · +$13
Price at note$445.28 (Oct 22 close) −8.8% downside (−$39.28) to the $406 target
CLFCleveland-Cliffs$13.90B. Riley Securities
RatingBuy unchanged
Price target$15 → $18 +20.0% · +$3
Price at note$13.05 (Oct 22 close) +37.9% upside (+$4.95) to the $18 target
CLFCleveland-Cliffs$13.90Barclays
RatingUnderweight unchanged
Price target$11 → $12 +9.1% · +$1
Price at note$13.05 (Oct 22 close) −8.0% downside (−$1.05) to the $12 target
CLFCleveland-Cliffs$13.90JP Morgan
RatingNeutral unchanged
Price target$12 → $13 +8.3% · +$1
Price at note$13.05 (Oct 22 close) −0.4% downside (−$0.05) to the $13 target
Wednesday · Oct 21, 2026
Morgan Stanley
RatingOverweight unchanged
Price target$141 → $132 −6.4% · −$9
Price at note$91.64 (Oct 21 close) +44.0% upside (+$40.36) to the $132 target
Wells Fargo
RatingOverweight unchanged
Price target$45 → $40 −11.1% · −$5
Price at note$28.12 (Oct 21 close) +42.2% upside (+$11.88) to the $40 target
TD Cowen
RatingBuy▼Hold
Price target$44 → $32 −27.3% · −$12
Price at note$28.12 (Oct 21 close) +13.8% upside (+$3.88) to the $32 target
Tuesday · Oct 20, 2026
CLFCleveland-Cliffs$13.90Morgan Stanley
RatingEqual-Weight unchanged
Price target$12.50 → $14 +12.0% · +$1.50
Price at note$13.65 (Oct 20 close) +2.6% upside (+$0.35) to the $14 target
CLFCleveland-Cliffs$13.90Wells Fargo
RatingOverweight unchanged
Price target$14 → $17 +21.4% · +$3
Price at note$13.65 (Oct 20 close) +24.5% upside (+$3.35) to the $17 target
Monday · Oct 19, 2026
VEEVVeeva Systems$323.04Barclays
RatingOverweight unchanged
Price target$315 → $360 +14.3% · +$45
Price at note$316.80 (Oct 19 close) +13.6% upside (+$43.20) to the $360 target
BMO Capital
RatingMarket Perform unchanged
Price target$105 → $97 −7.6% · −$8
Price at note$89.58 (Oct 19 close) +8.3% upside (+$7.42) to the $97 target
Citigroup
RatingBuy unchanged
Price target$45 → $43 −4.4% · −$2
Price at note$29.85 (Oct 19 close) +44.1% upside (+$13.15) to the $43 target
CLFCleveland-Cliffs$13.90Barclays
RatingUnderweight unchanged
Price target$10 → $11 +10.0% · +$1
Price at note$14.10 (Oct 19 close) −22.0% downside (−$3.10) to the $11 target
Friday · Oct 16, 2026
Barclays
RatingOverweight unchanged
Price target$118 → $115 −2.5% · −$3
Price at note$91.96 (Oct 16 close) +25.1% upside (+$23.04) to the $115 target
UBS
RatingBuy unchanged
Price target$113 → $109 −3.5% · −$4
Price at note$91.96 (Oct 16 close) +18.5% upside (+$17.04) to the $109 target
Wells Fargo
RatingEqual-Weight unchanged
Price target$105 → $103 −1.9% · −$2
Price at note$91.96 (Oct 16 close) +12.0% upside (+$11.04) to the $103 target
JP Morgan
RatingOverweight unchanged
Price target$150 → $147 −2.0% · −$3
Price at note$91.96 (Oct 16 close) +59.9% upside (+$55.04) to the $147 target
Evercore ISI Group
RatingIn-Line unchanged
Price target$107 → $104 −2.8% · −$3
Price at note$91.96 (Oct 16 close) +13.1% upside (+$12.04) to the $104 target
Truist Securities
RatingBuy unchanged
Price target$125 → $112 −10.4% · −$13
Price at note$91.96 (Oct 16 close) +21.8% upside (+$20.04) to the $112 target
ONONOn Holding AG$32.51
Raymond James
RatingOutperform unchanged
Price target$38 → $42 +10.5% · +$4
Price at note$34.75 (Oct 16 close) +20.9% upside (+$7.25) to the $42 target
FRMIFermi Inc.$2.55
Cantor Fitzgerald
RatingOverweight unchanged
Price target$12 → $8 −33.3% · −$4
Price at note$3.16 (Oct 16 close) +153.2% upside (+$4.84) to the $8 target
DISWalt Disney Company (The)$112.52Citigroup
RatingBuy unchanged
Price target$135 → $140 +3.7% · +$5
Price at note$110.59 (Oct 16 close) +26.6% upside (+$29.41) to the $140 target
Raymond James
RatingOutperform unchanged
Price target$42.50 → $37 −12.9% · −$5.50
Price at note$29.89 (Oct 16 close) +23.8% upside (+$7.11) to the $37 target
Oppenheimer
RatingOutperform unchanged
Price target$90 → $78 −13.3% · −$12
Price at note$54.65 (Oct 16 close) +42.7% upside (+$23.35) to the $78 target
Wells Fargo
RatingEqual-Weight unchanged
Price target$63 → $55 −12.7% · −$8
Price at note$54.65 (Oct 16 close) +0.6% upside (+$0.35) to the $55 target
Thursday · Oct 15, 2026
ZSZscaler, Inc.$212.53Citigroup
RatingBuy unchanged
Price target$245 → $260 +6.1% · +$15
Price at note$220.43 (Oct 15 close) +18.0% upside (+$39.57) to the $260 target
Citigroup
RatingNeutral unchanged
Price target$205 → $215 +4.9% · +$10
Price at note$208.52 (Oct 15 close) +3.1% upside (+$6.48) to the $215 target
Citigroup
RatingNeutral unchanged
Price target$360 → $350 −2.8% · −$10
Price at note$335.53 (Oct 15 close) +4.3% upside (+$14.47) to the $350 target
Morgan Stanley
RatingEqual-Weight unchanged
Price target$39 → $40 +2.6% · +$1
Price at note$30.58 (Oct 15 close) +30.8% upside (+$9.42) to the $40 target
Stephens & Co.
RatingEqual-Weight unchanged
Price target$40 → $38 −5.0% · −$2
Price at note$30.58 (Oct 15 close) +24.3% upside (+$7.42) to the $38 target
Wednesday · Oct 14, 2026
PLUGPlug Power, Inc.$1.38Susquehanna
RatingNeutral unchanged
Price target$2.50 → $1.75 −30.0% · −$0.75
Price at note$1.45 (Oct 14 close) +20.7% upside (+$0.30) to the $1.75 target
Truist Securities
RatingHold unchanged
Price target$352 → $361 +2.6% · +$9
Price at note$335.28 (Oct 14 close) +7.7% upside (+$25.72) to the $361 target
Barclays
RatingOverweight unchanged
Price target$420 → $425 +1.2% · +$5
Price at note$335.28 (Oct 14 close) +26.8% upside (+$89.72) to the $425 target
Morgan Stanley
RatingEqual-Weight unchanged
Price target$370 → $377 +1.9% · +$7
Price at note$335.28 (Oct 14 close) +12.4% upside (+$41.72) to the $377 target
Baird
RatingNeutral unchanged
Price target$305 → $312 +2.3% · +$7
Price at note$335.28 (Oct 14 close) −6.9% downside (−$23.28) to the $312 target
ICEIntercontinental Exchange$162.74Wells Fargo
RatingUnderweight unchanged
Price target$159 → $160 +0.6% · +$1
Price at note$155.11 (Oct 14 close) +3.2% upside (+$4.89) to the $160 target
Tuesday · Oct 13, 2026
Truist Securities
RatingBuy unchanged
Price target$130 → $125 −3.8% · −$5
Price at note$95.94 (Oct 13 close) +30.3% upside (+$29.06) to the $125 target
RSKDRiskified Ltd.$9.15Goldman Sachs
RatingSell unchanged
Price target$5.50 → $7.50 +36.4% · +$2
Price at note$8.46 (Oct 13 close) −11.3% downside (−$0.96) to the $7.50 target
Monday · Oct 12, 2026
TD Cowen
RatingBuy unchanged
Price target$128 → $129 +0.8% · +$1
Price at note$97.06 (Oct 12 close) +32.9% upside (+$31.94) to the $129 target
PIImpinj, Inc.$167.07Barclays
RatingOverweight unchanged
Price target$176 → $200 +13.6% · +$24
Price at note$190.04 (Oct 12 close) +5.2% upside (+$9.96) to the $200 target
ICEIntercontinental Exchange$162.74TD Cowen
RatingHold unchanged
Price target$166 → $167 +0.6% · +$1
Price at note$157.42 (Oct 12 close) +6.1% upside (+$9.58) to the $167 target
ELVElevance Health$439.95Guggenheim
RatingBuy unchanged
Price target$455 → $460 +1.1% · +$5
Price at note$422.09 (Oct 12 close) +9.0% upside (+$37.91) to the $460 target
Friday · Oct 9, 2026
ZSZscaler, Inc.$212.53Citizens
RatingMarket Outperform unchanged
Price target$210 → $265 +26.2% · +$55
Price at note$233.73 (Oct 9 close) +13.4% upside (+$31.27) to the $265 target
Morgan Stanley
RatingOverweight unchanged
Price target$136 → $141 +3.7% · +$5
Price at note$96.70 (Oct 9 close) +45.8% upside (+$44.30) to the $141 target
BMO Capital
RatingOutperform unchanged
Price target$230 → $245 +6.5% · +$15
Price at note$232.13 (Oct 9 close) +5.5% upside (+$12.87) to the $245 target
ICEIntercontinental Exchange$162.74Morgan Stanley
RatingEqual-Weight unchanged
Price target$163 → $173 +6.1% · +$10
Price at note$156.19 (Oct 9 close) +10.8% upside (+$16.81) to the $173 target
CLFCleveland-Cliffs$13.90JP Morgan
RatingNeutral unchanged
Price target$13 → $12 −7.7% · −$1
Price at note$12.98 (Oct 9 close) −7.6% downside (−$0.98) to the $12 target
Thursday · Oct 8, 2026
CYTKCytokinetics$61.23RBC Capital
RatingOutperform unchanged
Price target$112 → $113 +0.9% · +$1
Price at note$62.01 (Oct 8 close) +82.2% upside (+$50.99) to the $113 target
Truist Securities
RatingBuy unchanged
Price target$90 → $70 −22.2% · −$20
Price at note$53.81 (Oct 8 close) +30.1% upside (+$16.19) to the $70 target
Wednesday · Oct 7, 2026
ZSZscaler, Inc.$212.53Macquarie
RatingOutperform unchanged
Price target$200 → $250 +25.0% · +$50
Price at note$213.55 (Oct 7 close) +17.1% upside (+$36.45) to the $250 target
ZSZscaler, Inc.$212.53UBS
RatingBuy unchanged
Price target$225 → $250 +11.1% · +$25
Price at note$213.55 (Oct 7 close) +17.1% upside (+$36.45) to the $250 target
ZSZscaler, Inc.$212.53Citigroup
RatingBuy unchanged
Price target$205 → $245 +19.5% · +$40
Price at note$213.55 (Oct 7 close) +14.7% upside (+$31.45) to the $245 target
ZSZscaler, Inc.$212.53Jefferies
RatingBuy unchanged
Price target$220 → $250 +13.6% · +$30
Price at note$213.55 (Oct 7 close) +17.1% upside (+$36.45) to the $250 target
ZSZscaler, Inc.$212.53Canaccord Genuity
RatingBuy unchanged
Price target$210 → $250 +19.0% · +$40
Price at note$213.55 (Oct 7 close) +17.1% upside (+$36.45) to the $250 target
ZSZscaler, Inc.$212.53BNP Paribas
RatingOutperform unchanged
Price target$230 → $250 +8.7% · +$20
Price at note$213.55 (Oct 7 close) +17.1% upside (+$36.45) to the $250 target
ZSZscaler, Inc.$212.53Truist Securities
RatingBuy unchanged
Price target$200 → $250 +25.0% · +$50
Price at note$213.55 (Oct 7 close) +17.1% upside (+$36.45) to the $250 target
ZSZscaler, Inc.$212.53Scotiabank
RatingSector Outperform unchanged
Price target$240 → $255 +6.2% · +$15
Price at note$213.55 (Oct 7 close) +19.4% upside (+$41.45) to the $255 target
ZSZscaler, Inc.$212.53JP Morgan
RatingOverweight unchanged
Price target$215 → $245 +14.0% · +$30
Price at note$213.55 (Oct 7 close) +14.7% upside (+$31.45) to the $245 target
ZSZscaler, Inc.$212.53Wells Fargo
RatingOverweight unchanged
Price target$215 → $260 +20.9% · +$45
Price at note$213.55 (Oct 7 close) +21.8% upside (+$46.45) to the $260 target
ZSZscaler, Inc.$212.53Barclays
RatingOverweight unchanged
Price target$220 → $225 +2.3% · +$5
Price at note$213.55 (Oct 7 close) +5.4% upside (+$11.45) to the $225 target
ZSZscaler, Inc.$212.53Stephens & Co.
RatingOverweight unchanged
Price target$225 → $265 +17.8% · +$40
Price at note$213.55 (Oct 7 close) +24.1% upside (+$51.45) to the $265 target
ZSZscaler, Inc.$212.53TD Cowen
RatingBuy unchanged
Price target$200 → $230 +15.0% · +$30
Price at note$213.55 (Oct 7 close) +7.7% upside (+$16.45) to the $230 target
ZSZscaler, Inc.$212.53Stifel
RatingBuy unchanged
Price target$200 → $235 +17.5% · +$35
Price at note$213.55 (Oct 7 close) +10.0% upside (+$21.45) to the $235 target
ZSZscaler, Inc.$212.53Evercore ISI Group
RatingIn-Line unchanged
Price target$155 → $195 +25.8% · +$40
Price at note$213.55 (Oct 7 close) −8.7% downside (−$18.55) to the $195 target
ZSZscaler, Inc.$212.53Guggenheim
RatingBuy unchanged
Price target$214 → $254 +18.7% · +$40
Price at note$213.55 (Oct 7 close) +18.9% upside (+$40.45) to the $254 target
ZSZscaler, Inc.$212.53Wedbush
RatingOutperform unchanged
Price target$215 → $240 +11.6% · +$25
Price at note$213.55 (Oct 7 close) +12.4% upside (+$26.45) to the $240 target
ZSZscaler, Inc.$212.53Baird
RatingOutperform unchanged
Price target$230 → $285 +23.9% · +$55
Price at note$213.55 (Oct 7 close) +33.5% upside (+$71.45) to the $285 target
ZSZscaler, Inc.$212.53Cantor Fitzgerald
RatingOverweight unchanged
Price target$225 → $275 +22.2% · +$50
Price at note$213.55 (Oct 7 close) +28.8% upside (+$61.45) to the $275 target
ZSZscaler, Inc.$212.53Morgan Stanley
RatingEqual-Weight unchanged
Price target$165 → $185 +12.1% · +$20
Price at note$213.55 (Oct 7 close) −13.4% downside (−$28.55) to the $185 target
ZSZscaler, Inc.$212.53Needham
RatingBuy unchanged
Price target$215 → $255 +18.6% · +$40
Price at note$213.55 (Oct 7 close) +19.4% upside (+$41.45) to the $255 target
UBS
RatingBuy unchanged
Price target$128 → $113 −11.7% · −$15
Price at note$95.58 (Oct 7 close) +18.2% upside (+$17.42) to the $113 target
Barclays
RatingOverweight unchanged
Price target$125 → $118 −5.6% · −$7
Price at note$95.58 (Oct 7 close) +23.5% upside (+$22.42) to the $118 target
ICEIntercontinental Exchange$162.74Barclays
RatingOverweight unchanged
Price target$182 → $189 +3.8% · +$7
Price at note$152.59 (Oct 7 close) +23.9% upside (+$36.41) to the $189 target
ELVElevance Health$439.95Barclays
RatingOverweight unchanged
Price target$457 → $469 +2.6% · +$12
Price at note$404.31 (Oct 7 close) +16.0% upside (+$64.69) to the $469 target
RBC Capital
RatingOutperform▼Sector Perform
Price target$88 → $62 −29.5% · −$26
Price at note$53.55 (Oct 7 close) +15.8% upside (+$8.45) to the $62 target
ABGAsbury Automotive Group$172.65UBS
RatingNeutral unchanged
Price target$250 → $193 −22.8% · −$57
Price at note$167.77 (Oct 7 close) +15.0% upside (+$25.23) to the $193 target
Tuesday · Oct 6, 2026
CLFCleveland-Cliffs$13.90Wells Fargo
RatingEqual-Weight▲Overweight
Price target$12 → $14 +16.7% · +$2
Price at note$12.25 (Oct 6 close) +14.3% upside (+$1.75) to the $14 target
ABGAsbury Automotive Group$172.65JP Morgan
RatingUnderweight unchanged
Price target$190 → $185 −2.6% · −$5
Price at note$169.76 (Oct 6 close) +9.0% upside (+$15.24) to the $185 target
ABGAsbury Automotive Group$172.65Barclays
RatingEqual-Weight unchanged
Price target$265 → $230 −13.2% · −$35
Price at note$169.76 (Oct 6 close) +35.5% upside (+$60.24) to the $230 target
Monday · Oct 5, 2026
ZSZscaler, Inc.$212.53Scotiabank
RatingSector Outperform unchanged
Price target$200 → $240 +20.0% · +$40
Price at note$201.80 (Oct 5 close) +18.9% upside (+$38.20) to the $240 target
B of A Securities
RatingUnderperform unchanged
Price target$91 → $95 +4.4% · +$4
Price at note$97.96 (Oct 5 close) −3.0% downside (−$2.96) to the $95 target
UBS
RatingBuy unchanged
Price target$400 → $395 −1.2% · −$5
Price at note$330.73 (Oct 5 close) +19.4% upside (+$64.27) to the $395 target
ICEIntercontinental Exchange$162.74TD Cowen
RatingBuy▼Hold
Price target$177 → $166 −6.2% · −$11
Price at note$152.15 (Oct 5 close) +9.1% upside (+$13.85) to the $166 target
DISWalt Disney Company (The)$112.52Raymond James
RatingOutperform unchanged
Price target$120 → $119 −0.8% · −$1
Price at note$103.61 (Oct 5 close) +14.9% upside (+$15.39) to the $119 target
ABGAsbury Automotive Group$172.65Morgan Stanley
RatingEqual-Weight unchanged
Price target$230 → $184 −20.0% · −$46
Price at note$171.83 (Oct 5 close) +7.1% upside (+$12.17) to the $184 target
Friday · Oct 2, 2026
Piper Sandler
RatingNeutral unchanged
Price target$118 → $100 −15.3% · −$18
Price at note$96.70 (Oct 2 close) +3.4% upside (+$3.30) to the $100 target
ICEIntercontinental Exchange$162.74Piper Sandler
RatingOverweight unchanged
Price target$190 → $195 +2.6% · +$5
Price at note$150.15 (Oct 2 close) +29.9% upside (+$44.85) to the $195 target
Thursday · Oct 1, 2026
ONONOn Holding AG$32.51
JP Morgan
RatingOverweight unchanged
Price target$41 → $44 +7.3% · +$3
Price at note$30.20 (Oct 1 close) +45.7% upside (+$13.80) to the $44 target
JBLJabil$273.97JP Morgan
RatingOverweight unchanged
Price target$425 → $430 +1.2% · +$5
Price at note$299.79 (Oct 1 close) +43.4% upside (+$130.21) to the $430 target
JBLJabil$273.97Barclays
RatingOverweight unchanged
Price target$426 → $378 −11.3% · −$48
Price at note$299.79 (Oct 1 close) +26.1% upside (+$78.21) to the $378 target
StoneX
RatingBuy unchanged
Price target$100 → $85 −15.0% · −$15
Price at note$57.35 (Oct 1 close) +48.2% upside (+$27.65) to the $85 target
Tuesday · Sep 29, 2026
ZSZscaler, Inc.$212.53Barclays
RatingOverweight unchanged
Price target$200 → $220 +10.0% · +$20
Price at note$198.35 (Sep 29 close) +10.9% upside (+$21.65) to the $220 target
TD Securities
RatingBuy▼Sell
Price target$8 → $7.35 −8.1% · −$0.65
Price at note$4.93 (Sep 29 close) +49.1% upside (+$2.42) to the $7.35 target
Morgan Stanley
RatingOverweight unchanged
Price target$200 → $245 +22.5% · +$45
Price at note$204.88 (Sep 29 close) +19.6% upside (+$40.12) to the $245 target
JP Morgan
RatingOverweight unchanged
Price target$40 → $37 −7.5% · −$3
Price at note$31.88 (Sep 29 close) +16.1% upside (+$5.12) to the $37 target
Monday · Sep 28, 2026
SHELShell PLC$108.18TD Cowen
RatingBuy unchanged
Price target$107 → $115 +7.5% · +$8
Price at note$96.47 (Sep 28 close) +19.2% upside (+$18.53) to the $115 target
RSKDRiskified Ltd.$9.15Truist Securities
RatingBuy unchanged
Price target$7.50 → $9 +20.0% · +$1.50
Price at note$7.70 (Sep 28 close) +16.9% upside (+$1.30) to the $9 target
Scotiabank
RatingSector Outperform unchanged
Price target$190 → $245 +28.9% · +$55
Price at note$202.18 (Sep 28 close) +21.2% upside (+$42.82) to the $245 target
Citizens
RatingMarket Outperform unchanged
Price target$180 → $225 +25.0% · +$45
Price at note$202.18 (Sep 28 close) +11.3% upside (+$22.82) to the $225 target
HSBC
RatingHold unchanged
Price target$369 → $377 +2.2% · +$8
Price at note$334.92 (Sep 28 close) +12.6% upside (+$42.08) to the $377 target
FMCCFreddie Mac$3.71
Keefe, Bruyette & Woods
RatingUnderperform unchanged
Price target$6.50 → $3.50 −46.2% · −$3
Price at note$4 (Sep 28 close) −12.5% downside (−$0.50) to the $3.50 target
Friday · Sep 25, 2026
Macquarie
RatingOutperform unchanged
Price target$185 → $240 +29.7% · +$55
Price at note$195.19 (Sep 25 close) +23.0% upside (+$44.81) to the $240 target
Truist Securities
RatingBuy unchanged
Price target$200 → $235 +17.5% · +$35
Price at note$195.19 (Sep 25 close) +20.4% upside (+$39.81) to the $235 target
Stephens & Co.
RatingOverweight unchanged
Price target$190 → $240 +26.3% · +$50
Price at note$195.19 (Sep 25 close) +23.0% upside (+$44.81) to the $240 target
BMO Capital
RatingOutperform unchanged
Price target$187 → $230 +23.0% · +$43
Price at note$195.19 (Sep 25 close) +17.8% upside (+$34.81) to the $230 target
Baird
RatingOutperform unchanged
Price target$200 → $235 +17.5% · +$35
Price at note$195.19 (Sep 25 close) +20.4% upside (+$39.81) to the $235 target
ANDGAndersen Group Inc.$63.39Truist Securities
RatingBuy unchanged
Price target$55 → $70 +27.3% · +$15
Price at note$52.96 (Sep 25 close) +32.2% upside (+$17.04) to the $70 target
Source: Yahoo Finance analyst upgrades and downgrades (firm, rating, price target), refreshed after each US market close for the stocks Coteau covers. Yahoo doesn't name the individual analyst. "Price at note" is that day's closing price from our daily price history (the prior close when the note came before the open); the upside or downside is the distance from it to the new target. Details opens the matching news story when we have one, otherwise the stock's Yahoo Finance analysis page. Ratings and targets belong to the firms named; Coteau doesn't rate stocks, set targets or give advice. Not investment advice · Important disclosures
Get the market emails
Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdaysIndexes, sectors, biggest movers, rates, top news, Coteau model changes and what's ahead. Free, two short emails each weekday.
Check your inbox to confirm
We sent a link to . Tap it to start your emails. Nothing is sent until you confirm.
Not there in a minute? Check spam, or .
Dev mode No email provider here, so the confirm link is shown: Open confirm link
coteau
Free to use. No card, no ads, no auto-renew.
Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Coteau 0.9 · Oct 21, 2026